InnovHeart Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $9.3M

  • Investors
  • 6

InnovHeart General Information

Description

Developer of an implant technology designed to treat patients suffering from mitral valve disease. The company's technology focuses on replacing mitral valves based on an easy-to-use transcatheter technology, enabling hospitals to treat patients suffering from heart valve dysfunction safely and effectively.

Contact Information

Website
www.innovheart.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Giovannino de Grassi 11
  • 20123 Milan
  • Italy
+39 02
Primary Industry
Therapeutic Devices
Vertical(s)
HealthTech
Corporate Office
  • Via Giovannino de Grassi 11
  • 20123 Milan
  • Italy
+39 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InnovHeart Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 05-Dec-2025 $9.3M Completed Clinical Trials - General
3. Later Stage VC (Series C) 27-Jan-2022 Completed Clinical Trials - General
2. Later Stage VC (Series B) 30-Jul-2020 $22.9M $36.9M Completed Clinical Trials - General
1. Early Stage VC 22-Dec-2015 $14M $14M Completed Startup
To view InnovHeart’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

InnovHeart Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implant technology designed to treat patients suffering from mitral valve disease. The company's technol
Therapeutic Devices
Milan, Italy
25 As of 2025

Herzliya, Israel
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnovHeart Competitors (27)

One of InnovHeart’s 27 competitors is Valcare Medical, a Venture Capital-Backed company based in Herzliya, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valcare Medical Venture Capital-Backed Herzliya, Israel
JenaValve Technology Private Equity-Backed Irvine, CA
Tripair Venture Capital-Backed Hilden, Germany
Foldax Venture Capital-Backed Salt Lake City, UT
CoreMedic Venture Capital-Backed Radolfzell, Germany
You’re viewing 5 of 27 competitors. Get the full list »

InnovHeart Patents

  • 127

    Total Documents Applications and Grants

  • Total Patents Families

  • 96

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

InnovHeart Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4442308-A1 Access device for introducing elongated devices into the body of a living being Inactive 03-Apr-2023
US-20260240670-A1 Procedure, instruments and crimper for crimping an implantable device Pending 14-Mar-2023
AU-2024234603-A1 Procedure, tools and crimping tool for crimping an implantable device Pending 14-Mar-2023
EP-4680164-A1 Procedure, tools and crimping tool for crimping an implantable device Pending 14-Mar-2023
WO-2024189528-A1 Procedure, tools and crimping tool for crimping an implantable device Inactive 14-Mar-2023 A61F2/9524
To view InnovHeart’s complete patent history, request access »

InnovHeart Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnovHeart Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tech and Biomedical Foundation Venture Capital Minority
Grand Pharmaceutical Holding Company Minority
CDP Venture Capital (Rome) Venture Capital Minority
Indaco Venture Partners Venture Capital Minority
Panakes Partners Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

InnovHeart FAQs

  • When was InnovHeart founded?

    InnovHeart was founded in 2015.

  • Where is InnovHeart headquartered?

    InnovHeart is headquartered in Milan, Italy.

  • What is the size of InnovHeart?

    InnovHeart has 25 total employees.

  • What industry is InnovHeart in?

    InnovHeart’s primary industry is Therapeutic Devices.

  • Is InnovHeart a private or public company?

    InnovHeart is a Private company.

  • What is the current valuation of InnovHeart?

    The current valuation of InnovHeart is .

  • What is InnovHeart’s current revenue?

    The current revenue for InnovHeart is .

  • How much funding has InnovHeart raised over time?

    InnovHeart has raised $73.4M.

  • Who are InnovHeart’s investors?

    Tech and Biomedical Foundation, Grand Pharmaceutical, CDP Venture Capital (Rome), Indaco Venture Partners, and Panakes Partners are 5 of 6 investors who have invested in InnovHeart.

  • Who are InnovHeart’s competitors?

    Valcare Medical, JenaValve Technology, Tripair, Foldax, and CoreMedic are some of the 27 competitors of InnovHeart.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process